Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SGNC Sanguine Corp. Info Thread -- Ignore unavailable to you. Want to Upgrade?

To: Hope who wrote (84)	8/26/1998 10:12:00 AM
From: Dixie7777	Read Replies (1) \| Respond to of 100

The good Dr. should have made sure that his PR company included names and symbols of *all* current blood substitute researchers/manufacturer's, including the ones that failed, in the PR so that this news release would have *popped* on all the attendant investors screens. A good PR company, and I have no reason to believe that this firm is not a very good one, but they should look for as wide a dissemination of this PR as possible. Very possibly they don't understand how the PR's integrate to all the on-line information services and further integrate to the individual screens in peoples offices and homes. Jeeesh, if we could include even the most obscure reference to Baxter, J&J, Pfizer, Merck, Abbott Labs, even Microsoft, (only kidding, I think,) etc., we would get millions of more eyeball's looking at this PR. Don't forget to also include the ticker symbols of these companies in the PR. Not really difficult and maybe they can do a re-word and re-release again this AM. Quickly though so as not to lose the moment. Rich